Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
ATAI Quote, Financials, Valuation and Earnings
Last price:
$2.79
Seasonality move
:
-24.68%
Day range:
$2.59 - $2.71
52-week range:
$1.03 - $2.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
238.41x
P/B ratio:
3.56x
Volume:
2.3M
Avg. volume:
4.9M
1-year change:
64.63%
Market cap:
$540.9M
Revenue:
$308K
EPS (TTM):
-$0.91
Earnings Data
Next earnings date for ATAI
Aug 13
2025
Most recent earnings per share
-$0.15
Beat by $0.03
(May 14/2025)
Consensus Estimate
-$0.18
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATAI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.12 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.12 | -- |
| 05/14/2025 | Q1 | -- | $1.6M | -$0.15 | -$0.18 | $0.03 |
| 12/31/2024 | Q4 | $250K | -$5K | -$0.24 | -$0.15 | -$0.09 |
| 11/13/2024 | Q3 | -- | $40K | -$0.16 | -$0.16 | -- |
| 08/13/2024 | Q2 | -- | $273K | -$0.36 | -$0.16 | -$0.20 |
| 05/15/2024 | Q1 | -- | -- | -$0.17 | -$0.18 | $0.01 |
| 03/22/2024 | Q4 | $134K | $18K | -$0.11 | -$0.16 | $0.05 |
| 11/14/2023 | Q3 | -- | -- | $0.25 | -$0.20 | $0.45 |
| 06/30/2023 | Q2 | -- | -- | -$0.21 | -$0.21 | -$0.00 |
| 03/31/2023 | Q1 | -- | -- | -$0.21 | -$0.22 | $0.01 |
| 12/31/2022 | Q4 | -- | -- | -$0.28 | -$0.23 | -$0.05 |
| 09/30/2022 | Q3 | -- | -- | -$0.22 | -$0.24 | $0.02 |
| 06/30/2022 | Q2 | -- | -- | -$0.24 | -$0.24 | $0.00 |
| 03/31/2022 | Q1 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 12/31/2021 | Q4 | -- | -- | -$0.62 | -$0.25 | -$0.37 |
| 09/30/2021 | Q3 | -- | -- | -$0.21 | -$0.22 | $0.01 |
| 06/30/2021 | Q2 | -- | -- | -$0.37 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.55 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.11 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.11 | -- | -- |
ATAI Life Sciences NV Earnings Questions
-
How Much did ATAI Life Sciences NV Generate in Revenue Last Quarter?
ATAI Life Sciences NV reported $1.6M worth of top line sales in its most recent quarter.
-
Did ATAI Life Sciences NV Beat Earnings Last Quarter?
ATAI Life Sciences NV announced earnings per share of -$0.15 which represents a beat of analyst forecast a -$0.18 per share.
-
Is ATAI Life Sciences NV Profitable?
ATAI Life Sciences NV reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ATAI Life Sciences NV EPS Next Year?
ATAI Life Sciences NV's earnings are forecast to decrease from -$0.93 per share to -$0.76 per share next year representing a decrease of -46.24%.
-
When is ATAI Life Sciences NV's Earnings Date?
ATAI Life Sciences NV's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
